Andrew G. Bert
Impact in
- Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 1%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- Signaling Pathways in Disease
Papers in
-
- MicroRNA in disease regulation 16
- Cancer-related molecular mechanisms research 13
-
- Signaling Pathways in Disease 8
- Circular RNAs in diseases 8
- RNA Research and Splicing 8
- RNA Interference and Gene Delivery 4
- Co-authors
- Gregory J. GoodallPhilip A. GregoryYeesim Khew‐GoodallMathew A. VadasEmily PatersonGelareh FarshidAnna TsykinSimon C. Barry
- Journals
- The Journal of Immunology (3 papers)Proceedings of the National Academy of Sciences (3 papers)Molecular and Cellular Biology (3 papers)Scientific Reports (2 papers)Nucleic Acids Research (2 papers)
- Partner nations
- AustraliaUnited KingdomMalaysia
In The Last Decade
Andrew G. Bert
43 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 4.3k
- Molecular Biology 5.7k
- Oncology 1.7k
- Immunology 861
- Cell Biology 446
Countries citing papers authored by Andrew G. Bert
This map shows the geographic impact of Andrew G. Bert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew G. Bert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew G. Bert more than expected).
Fields of papers citing papers by Andrew G. Bert
This network shows the impact of papers produced by Andrew G. Bert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew G. Bert. The network helps show where Andrew G. Bert may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew G. Bert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 1 | |
| 3 | Nuclear export of circular RNA Hit paper breakdown → | 2024 | 60 |
| 4 | 2023 | 16 | |
| 5 | 2019 | 7 | |
| 6 | 2015 | 23 | |
| 7 | 2014 | 58 | |
| 8 | 2013 | 26 | |
| 9 | 2013 | 22 | |
| 10 | 2013 | 136 | |
| 11 | 2013 | 161 | |
| 12 | 2011 | 473 | |
| 13 | 2010 | 17 | |
| 14 | 2006 | 101 | |
| 15 | 2004 | 79 | |
| 16 | 2001 | 31 | |
| 17 | 2000 | 34 | |
| 18 | 2000 | 56 | |
| 19 | 1997 | 71 | |
| 20 | 1995 | 119 |
About Andrew G. Bert
Andrew G. Bert is a scholar working on Cancer Research, Molecular Biology, Immunology and Allergy, Immunology and Hematology, having authored 43 papers that have together received 7.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (13 papers), Signaling Pathways in Disease (8 papers), Circular RNAs in diseases (8 papers), RNA Research and Splicing (8 papers), Cancer Cells and Metastasis (6 papers), Immune Response and Inflammation (5 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Cancer Research (4.3k citations), Molecular Biology (5.7k citations), Oncology (1.7k citations), Immunology (861 citations) and Cell Biology (446 citations). Andrew G. Bert has collaborated with scholars based in Australia, United Kingdom and Malaysia. Frequent co-authors include Gregory J. Goodall, Philip A. Gregory, Yeesim Khew‐Goodall, Mathew A. Vadas, Emily Paterson, Gelareh Farshid, Anna Tsykin, Simon C. Barry, Cameron P. Bracken and M Shannon. Their work appears in journals such as The Journal of Immunology, Proceedings of the National Academy of Sciences, Molecular and Cellular Biology, Scientific Reports and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.